CD44 and neoplasm: By characterizing these novel molecular tumor markers, we hope to advance our understanding of the molecular and biological mechanisms involved in carcinogenesis and tumor progression and to find unique CD44 isoform and expression fingerprints of the varying cell types present in tumors.